OneSpaWorld (OSW) Q2 2026 Earnings Call Transcript

OneSpaWorld reported Q2 2026 total revenues of $261.2M (+9% YoY) and adjusted EBITDA of $34.4M (+13%), with growth driven by a 4% increase in revenue days and a 1.2% rise in average guest spend. The company raised FY2026 guidance to $1.018B–$1.038B revenue and $130M–$140M adjusted EBITDA (both ~10% growth at the midpoint). AI platforms (Amanda/AVA/Serena/Claude) are deployed across 188–202 vessels, contributing a 4% service revenue uplift for less experienced managers and resolving 96% of support tickets without human intervention, while prebooked revenue grew 14% and forward bookings were up 20%.

Analysis

OSW’s real advantage is not the headline growth rate; it is the steadily improving monetization of a captive customer base with very low acquisition cost. The important second-order effect is that prebooking and AI-driven recommendations widen the revenue surface area per sailing without requiring a step-up in cruise line traffic, which should keep incremental margins above the company’s historical average even if top-line growth normalizes. The newer wellness modalities are also strategically valuable because they are less promotional and more consultative, making them harder for cruise partners to replicate in-house.

The main near-term risk is that the market over-anchors on AI as a margin story when the first-order benefit is still revenue conversion, not a visible step-function in cost savings. That means the stock can disappoint if Q3/Q4 show only modest guest-spend acceleration or if European itinerary softness becomes a broader occupancy issue; those would hit the mix before they hit occupancy headlines. Over 6-18 months, the bigger structural catalyst is regulatory clarity around peptides/GLP-1s and whether OSW can convert wellness into a higher-frequency, higher-ticket category onboard.

Consensus may be underestimating how much of this is a quality-of-earnings story rather than a pure growth story: disciplined capex, falling interest expense, and share repurchases give downside support even if revenue slows. The counterpoint is that management’s AI narrative could become self-limiting if investors expect rapid EBITDA leverage that the business, with lean staffing and partner-driven economics, may not deliver. The thesis is falsified if average guest spend stalls below low-single-digit growth for two quarters or if Q3 guidance proves to be the peak rather than a stepping stone.

Key Decisions for Investors

• Go long OSW on pullbacks after the print; target a 1-3 month hold as bookings and prebook mix should re-rate the multiple before AI cost savings become visible. Falsify on average guest spend below ~1% YoY or a Q3 guide miss versus the newly raised range.
• Pair trade: long OSW / short NCLH for the next 1-3 months. OSW has cleaner ancillary monetization and less direct exposure to ticket price competition; the short works if Europe softness or broader cruise demand slows onboard yield, but cover if Caribbean/Alaska strength broadens again.
• Buy OSW Jan-2027 call spreads rather than outright calls if seeking exposure to the 2027 peptide/GLP-1 optionality. The spread limits premium burn while keeping upside to a favorable regulatory shift and a new high-ticket wellness category.
• Watchlist alert, not a trade yet: if OSW starts showing sustained EBITDA margin expansion despite only mid-single-digit revenue growth, that would validate AI as a real operating lever and justify adding on a second leg. Until then, treat AI as an upside optionality story, not the core valuation driver.